RECOMBINANT INTERFERON-ALPHA-2B IN THE TREATMENT OF POLYCYTHEMIA-VERA

被引:30
作者
CIMINO, R [1 ]
RAMETTA, V [1 ]
MATERA, C [1 ]
MELE, G [1 ]
METTIVIER, V [1 ]
FERRARA, F [1 ]
机构
[1] CARDARELLI GEN HOSP,DIV HEMATOL,NAPLES,ITALY
关键词
ALPHA-INTERFERON; PHLEBOTOMY; SPLENOMEGALY;
D O I
10.1002/ajh.2830440303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the effects of recombinant alpha2-b interferon (alpha2-b IFN) in a dose of 3 x 10(6) U intramuscularly three times a week for 1 year in 13 patients affected by polycythemia vera (PV) previously treated with phlebotomy only. Response to treatment was evaluated by reduction of the number of phlebotomies required to retain normal hematocrit value. Ten out of 13 patients (77%) responded to treatment; in 4 of them the exigency of phlebotomy was completely eliminated. In all responders a concomitant decrease of platelet count and splenomegaly was obtained. Treatment was well tolerated and side effects were easily controlled. We conclude that alpha-IFN may represent an attractive therapeutic option in the management of the proliferative stages of PV. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:155 / 157
页数:3
相关论文
共 16 条
[1]  
BERK PD, 1986, SEMIN HEMATOL, V23, P132
[2]   ALPHA-INTERFERON FOR INTRACTABLE PRURITUS IN POLYCYTHEMIA-VERA [J].
DEWOLF, JTM ;
HENDRIKS, DW ;
EGGER, RC ;
ESSELINK, MT ;
HALIE, MR ;
VELLENGA, E .
LANCET, 1991, 337 (8735) :241-241
[3]  
DUKES PP, 1980, EXP HEMATOL, V8, P1048
[4]   THE CURRENT STATUS OF INTERFERON-ALPHA IN HEMIC MALIGNANCY [J].
GALVANI, DW ;
CAWLEY, JC .
BLOOD REVIEWS, 1990, 4 (03) :175-180
[5]  
GARDNER FH, 1986, SEMIN HEMATOL, V3, P220
[6]  
GILES FJ, 1988, LANCET, V2, P70
[7]   LONG-TERM INTERFERON THERAPY FOR THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASES [J].
GISSLINGER, H ;
LUDWIG, H ;
LINKESCH, W ;
CHOTT, A ;
FRITZ, E ;
RADASZKIEWICZ, T .
LANCET, 1989, 1 (8639) :634-637
[8]  
GUGLIELMO P, 1990, BLOOD S, V76, pA277
[9]  
MURPHY S, 1989, HEMATOLOGY, P193
[10]  
NEUMANN HA, 1982, EXP HEMATOL, V10, P587